No impact on the incidence rate of adenoidectomy 1998‐2014 on a national level in Denmark by the use of nasal steroid and the introduction of pneumococcal vaccines
Abstract:The adenoid or pharyngeal tonsil is lymphoid tissue placed on the upper and posterior part of the nasopharynx. The adenoid is part of Waldeyer's ring (the pharyngeal, tubal, palatine and lingual tonsils as well as small collections of mucosal lined lymphatic tissue in the pharynx). The tissue is a first-line defence mediating a local and regional immune function when exposed to antigens from outside the body as well as the alimentary tract. Certain conditions can make the lymphoid tissue grow larger which resu… Show more
“…The recent rising trend in rates of ADT and AD particularly among younger aged children has also been reported in other countries including Scotland 13 and Australia, 11 while rates of AD have remained stable in Denmark, 14 and ADT rates have decreased in the US in recent years. 15 One of the main factors that has been attributed to the increase in ADT is the growing number of young children being diagnosed with, and treated for, OSA or less severe forms of disordered breathing.…”
Aim: To investigate the impact of adenotonsillectomy (ADT) and adenoidectomy (AD) on child health and evaluated their post-operative complications. Methods: We included all children aged <16 years undergoing ADT (tonsillectomy AE adenoidectomy) or AD in New South Wales, Australia, 2008-2017. Health information was obtained from administrative hospitalisation data. Rates of post-operative complications and reoperation were evaluated using generalised estimating equations and Kaplan-Meier methods, respectively. Results: Out of 156 500 included children, 112 361 had ADT and 44 139 had AD. Population rates increased during 2008-2017 (ADT: 68-79 per 10 000 children; AD: 25-34 per 10 000), and children were increasingly operated on at a younger age. Overall, 7262 (6.5%) and 1276 (2.9%) children had post-operative complications (mostly haemorrhage), and 4320 (3.8%) and 5394 (12.2%) required reoperation, following ADT and AD, respectively. Complication rates were highest among children aged 0-1 years, lowest for those 2-5 years and increased with age thereafter. Three-year reoperation rates for children aged 0-1 years were 9.0% and 25.9% following ADT and AD, respectively, decreasing thereafter to 0.5% and 2.1% in children aged 12-13 years. Conclusions: ADT and AD in Australian children have both increased in frequency and are being done at a younger age. Post-operative complications and reoperation rates highlight surgery is not without risk, especially for children under 2 years old. These findings support a more conservative approach to management of upper respiratory symptoms, with surgery reserved for cases where potential benefits are most likely to outweigh harms.
“…The recent rising trend in rates of ADT and AD particularly among younger aged children has also been reported in other countries including Scotland 13 and Australia, 11 while rates of AD have remained stable in Denmark, 14 and ADT rates have decreased in the US in recent years. 15 One of the main factors that has been attributed to the increase in ADT is the growing number of young children being diagnosed with, and treated for, OSA or less severe forms of disordered breathing.…”
Aim: To investigate the impact of adenotonsillectomy (ADT) and adenoidectomy (AD) on child health and evaluated their post-operative complications. Methods: We included all children aged <16 years undergoing ADT (tonsillectomy AE adenoidectomy) or AD in New South Wales, Australia, 2008-2017. Health information was obtained from administrative hospitalisation data. Rates of post-operative complications and reoperation were evaluated using generalised estimating equations and Kaplan-Meier methods, respectively. Results: Out of 156 500 included children, 112 361 had ADT and 44 139 had AD. Population rates increased during 2008-2017 (ADT: 68-79 per 10 000 children; AD: 25-34 per 10 000), and children were increasingly operated on at a younger age. Overall, 7262 (6.5%) and 1276 (2.9%) children had post-operative complications (mostly haemorrhage), and 4320 (3.8%) and 5394 (12.2%) required reoperation, following ADT and AD, respectively. Complication rates were highest among children aged 0-1 years, lowest for those 2-5 years and increased with age thereafter. Three-year reoperation rates for children aged 0-1 years were 9.0% and 25.9% following ADT and AD, respectively, decreasing thereafter to 0.5% and 2.1% in children aged 12-13 years. Conclusions: ADT and AD in Australian children have both increased in frequency and are being done at a younger age. Post-operative complications and reoperation rates highlight surgery is not without risk, especially for children under 2 years old. These findings support a more conservative approach to management of upper respiratory symptoms, with surgery reserved for cases where potential benefits are most likely to outweigh harms.
Adenoidectomy is the most common surgical intervention in pediatric otorhinolaryngological practice. Adenoids are detected in 65-80% of frequently ill children and cause many comorbid pathological conditions and diseases. Notably, when deciding on the need for adenoidectomy, there is always a concern that removal of the pharyngeal tonsil, which is the main producer of interferon and secretory IgA, may lead to an increase in acute inflam matory diseases of the upper respiratory tract or aggravation of their course. We analyzed the long-term results of adenoidectomy in 45 children. It was found that adenoidectomy led to the complete disappearance of all pathological manifestations in 73% of children and significant clinical improvement in 27%. The most significant result was obtained in the group of frequently ill children.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.